RSV

Dec 31, 2019

Respiratory Syncytial Virus (RSV): Forecast in Asia-Pacific Markets to 2028

Nov 04, 2019

Respiratory Syncytial Virus: Epidemiology Forecast in Asia-Pacific Markets to 2028

Oct 09, 2019

New Research Examines Key Players Involved in Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) Targeted Therapeutics Markets and Key Projects

Sep 10, 2019

Pneumagen Ltd Demonstrates Preclinical Proof-of-Concept for Neumifil(TM) in Respiratory Syncytial Virus Infections

Sep 03, 2019

Janssen Announces U.S. FDA Breakthrough Therapy Designation for Investigational Prophylactic Vaccine for the Prevention of Respiratory Syncytial Virus in Older Adults

Jul 29, 2019

Mesa Biotech to Launch Molecular, Sample-to-Answer RSV Test at the 2019 AACC Annual Scientific Meeting

Nov 27, 2018

Mesa Biotech Receives FDA 510(k) Clearance and CLIA Waiver for Its Accula(TM) RSV Molecular Point of Care Test

Nov 13, 2018

Mesa Biotech Obtains CE Mark for its Accula RSV Molecular Point of Care Test

Apr 23, 2018

Global Respiratory Syncytial Virus (RSV) Therapeutics Market to Reach US$ 2120.0 Million by 2025, Says TMR